Clinical trials
Glioblastoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
194 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 5 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 8 |
| 2013 | 4 |
| 2014 | 7 |
| 2015 | 6 |
| 2016 | 10 |
| 2017 | 9 |
| 2018 | 16 |
| 2019 | 18 |
| 2020 | 22 |
| 2021 | 21 |
| 2022 | 15 |
| 2023 | 10 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 194 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huashan Hospital | 6 |
| Beijing Tiantan Hospital | 5 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Sun Yat-sen University | 4 |
| NovoCure Ltd. | 3 |
| Shandong Cancer Hospital and Institute | 3 |
| TransMolecular | 3 |
| Adnexus, A Bristol-Myers Squibb R&D Company | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Assistance Publique Hopitaux De Marseille | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 194 |
| Glioma | 43 |
| Brain Neoplasms | 34 |
| Astrocytoma | 27 |
| Gliosarcoma | 21 |
| Central Nervous System Neoplasms | 16 |
| Oligodendroglioma | 16 |
| Neoplasms | 9 |
| Recurrence | 7 |
| Ependymoma | 5 |
Trials
Showing 51 to 75 of 194. Each trial links to its page on Pharma Observatory.
94 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.